pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda medwatch·Aug 26·1 min read
save

Boston Scientific recalls ENROUTE Transcarotid Neuroprotection System after sheath tip separation reports

Aug 26, 2026·read at fda medwatch ↗CRLNegative

Boston Scientific announced a recall of its ENROUTE Transcarotid Neuroprotection System and the ENROUTE Transcarotid Neuroprotection System Plus.

The FDA classified the recall as the most serious type because the arterial sheath tip may separate during use, creating a risk of serious injury or death.

In a letter dated July 9, Boston Scientific instructed customers to immediately stop using the devices, segregate them, return them to the company, and notify relevant personnel.

Facilities are also advised to contact any other locations that may have received the affected lots and provide the same notice.

source

This writeup was produced by pharmadog from original reporting by fda medwatch.

Original headline: “Percutaneous Catheter Recall: Boston Scientific Removes ENROUTE Transcarotid Neuroprotection System”

read at fda medwatch ↗
485 words · retrieved Aug 26
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
BOSTON SCIENTIFIC CORP9Silk Road TherapeuticsUNIQUE
topics
Recall8Hematology

related stories

  • Sep 25Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Cathetersfda medwatch
  • 5d agoInfusion Set Recall: BD and CareFusion 303, Inc. Remove BD Alaris Pump Infusion Setsfda medwatch
  • Sep 15Esophageal pH Monitoring Capsule Recall: Medtronic and Given Imaging Remove Esophageal pH Monitoring Capsule Delivery Devicefda medwatch
  • Sep 3Spinal Cord Stimulator Recall: Boston Scientific Removes Infinion CX Leadfda medwatch
  • Sep 2Catheter Recall Expansion: Medline Industries Removes Reprocessed Electrophysiology and Ultrasound Cathetersfda medwatch